title: Severe scalp hair loss in a female patient with acromegaly treated with lanreotide autogel after unsuccessful surgery.
abstract: Scalp hair loss is an underreported adverse event of somatostatin analogs therapy that in severe cases may require treatment withdrawal. It can be related to an acute decrease in GH/IGF-1 levels, but a direct effect cannot be ruled out.
authors.affiliation: Endocrinology Department, La Paz University Hospital Paseo de La Castellana 261, 28046 Madrid, Spain.
authors.forename: Cristina
authors.initials: C
authors.lastname: Alvarez-Escola
authors.affiliation: Endocrinology Department, La Paz University Hospital Paseo de La Castellana 261, 28046 Madrid, Spain.
authors.forename: Jersy J
authors.initials: JJ
authors.lastname: Cárdenas-Salas
authors.affiliation: Endocrinology Department, La Paz University Hospital Paseo de La Castellana 261, 28046 Madrid, Spain.
authors.forename: Beatriz
authors.initials: B
authors.lastname: Pelegrina
authors.affiliation: Endocrinology Department, La Paz University Hospital Paseo de La Castellana 261, 28046 Madrid, Spain.
authors.forename: Angel
authors.initials: A
authors.lastname: Sanz-Valtierra
authors.affiliation: Endocrinology Department, La Paz University Hospital Paseo de La Castellana 261, 28046 Madrid, Spain.
authors.forename: Beatriz
authors.initials: B
authors.lastname: Lecumberri
keywords: Lanreotide; alopecia; hair loss; somatostatin analogs